FDA Inspection 1114160 — Stasinos Sikalias
The FDA completed an inspection of Stasinos Sikalias on May 17, 2019 in Peristeri. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Peristeri (Greece)
Additional details
Mutual Recognition Agreement (MRA)